NASDAQ: IPSCCentury Therapeutics Inc Stock Ownership - Who owns Century Therapeutics?
Insider buying vs selling
Have Century Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Douglas Carr | SVP | 2026-11-03 | 266 | $1.52 | $404.05Sell |
| Gregory Russotti | CTO | 2026-09-14 | 2,587 | $1.93 | $4.99kSell |
| Douglas Carr | SVP | 2026-09-14 | 1,658 | $1.93 | $3.20kSell |
| Brent Pfeiffenberger | CEO;Pres | 2026-09-11 | 13,850 | $1.94 | $26.87kSell |
| Douglas Carr | SVP | 2026-09-08 | 254 | $2.05 | $520.70Sell |
| Gregory Russotti | CTO | 2026-09-08 | 534 | $2.05 | $1.09kSell |
| Brent Pfeiffenberger | CEO;Pres | 2026-09-04 | 463 | $2.11 | $976.93Sell |
| Brent Pfeiffenberger | CEO;Pres | 2026-08-14 | 31,172 | $1.92 | $59.85kSell |
| Douglas Carr | SVP | 2026-08-03 | 275 | $1.98 | $543.68Sell |
| Gregory Russotti | Title Chief Technology and Manufacturing Officer | 2026-06-12 | 2,584 | $2.23 | $5.77kSell |
IPSC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IPSC insiders and whales buy or sell their stock.
IPSC Shareholders
What type of owners hold Century Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Aktiengesellschaft Bayer | 7.00% | 12,675,838 | $20.66M | Insider |
| Versant Venture Capital VI LP | 6.72% | 12,166,109 | $19.83M | Insider |
| Fujifilm Cellular Dynamics Inc | 3.84% | 6,955,207 | $11.34M | Insider |
| Brent Pfeiffenberger | 2.01% | 3,633,839 | $5.92M | Insider |
| Eli Casdin | 1.77% | 3,206,380 | $5.23M | Insider |
| Chad Cowan | 0.65% | 1,186,019 | $1.93M | Insider |
| Gregory Russotti | 0.38% | 694,744 | $1.13M | Insider |
| Hyam Levitsky | 0.31% | 560,544 | $913.69k | Insider |
| Douglas Carr | 0.28% | 502,641 | $819.30k | Insider |
| Luis Borges | 0.14% | 256,535 | $418.15k | Insider |
IPSC vs Biotech Stocks
Century Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.